|
Market Closed -
London S.E.
10:05:02 30/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 11.75 GBX | 0.00% |
|
+17.50% | - |
| 22/10 | Synthomer is cash positive; Arbuthnot lifts outlook | AN |
| 22/10 | Ixico Wins New Contract, Extension Totaling GBP1.5 Million | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.45Cr | - | ||||
| 6.38TCr | |||||
| 5.64TCr | |||||
| 5.46TCr | |||||
| 4.41TCr | |||||
| 4.21TCr |
- Stock Market
- Stocks
- IXI Stock
- Charts IXICO plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
